Press Release

NKS Health & Blue Charm Adherence Announce Strategic Collaboration

October 19, 2021
Return to all articles

NKS Health & Blue Charm Adherence Announce Strategic Collaboration on Digital Health Program for People Living With MS

Halifax, N.S. and Toronto, ON – October 19, 2021 – Blue Charm Adherence, a digital health solutions provider for the life sciences industry, is excited to announce a strategic collaboration with NKS Health, a leading specialty pharmacy serving all of Canada. NKS Health will launch the Blue Charm digital health platform across its national network of pharmacies to improve patient engagement and generate actionable insights through new sources of real-world data (RWD).

Through this partnership, NKS patients living with multiple sclerosis (MS) and prescribed a disease-modifying therapy (DMT) will have the opportunity to join Blue Charm's six-month Early Adopter Program. This program provides patients with access to the Blue Charm digital health platform and funding towards medication costs and eligible health-related expenses.

"We are thrilled to be working with NKS Health on bringing our digital health program to more patients across Canada," said Greg Patey, CEO, Blue Charm Adherence. "People living with MS face unique challenges throughout their care journey that we hope to help address with this program."

Don Swainson, Team Lead – National Programs, NKS Health & NKS Assist, added, "People with MS have a lot to deal with. The Blue Charm adherence tool should help patients who require a high-tech helper, to get the most from their medication. NKS is very pleased with this collaboration and look forward to learning from this pilot program."

About NKS HealthEstablished in 2007, NKS Health is a specialty pharmaceutical services company focused on the handling and service of injectable, infused, and biologic medications. NKS Health provides high-quality service by strategically focusing on chronic autoimmune and neurological conditions such as: rheumatoid arthritis, gastrointestinal diseases, dermatological diseases, stroke rehabilitation, migraines, and multiple sclerosis.

About Blue Charm AdherenceFounded in 2018, Blue Charm Adherence is a Canadian healthcare technology company. Blue Charm provides digital health infrastructure for life sciences companies, allowing them to deliver reward-based programs, collect real-world data (RWD) between appointments, and drive long-term patient engagement.

For further information about Blue Charm programs and services, including those in MS and other chronic diseases, please contact:

Dr. Greg Patey
CEO, Blue Charm Adherence
Email: g.patey@bluecharm.io

Articles you might like

Insights

Exploring the Link Between Genetics and Obesity

The following article discusses the significant role genetics play in obesity, alongside lifestyle factors like diet and exercise. It highlights specific genetic variants, such as those in the FTO and MC4R genes, that increase susceptibility to obesity by affecting appetite, metabolism, and energy storage. This emphasizes the need to understand obesity's multifactorial nature to avoid stigma and promote comprehensive health strategies that include genetic insights for personalized interventions.
Insights

Living with Inflammatory Bowel Disease (IBD): Navigating the Impact on Quality of Life

The following article discusses how IBD affects daily life with unpredictable flare-ups causing severe symptoms like pain and fatigue, significantly impacting physical and mental well-being. A survey found that 94% of people with IBD experience regular disruptions to their quality of life. Despite these challenges, coping strategies such as building a support network and seeking medical advice can help manage the condition.
Insights

The Crucial Need for Timely Access to Healthcare Professionals in Canada

The article highlights the critical importance of timely access to healthcare in Canada, underscoring it as a cornerstone of societal function. Despite the country's celebrated universal healthcare system, challenges such as varying wait times for specialists and diagnostic tests persist across provinces and territories. Access to healthcare professionals is crucial not only for managing chronic conditions effectively but also for early detection and treatment, thus directly influencing health outcomes and overall quality of life for Canadians.